| 51 | 6688970 | A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL). | Cancer Chemother Pharmacol | 1983 |
1 |
| 52 | 6697295 | Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality. | Cancer | 1984 Apr 1 |
3 |
| 53 | 6950800 | Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin. | Cancer | 1982 Apr 15 |
3 |
| 54 | 7000347 | Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy. | Cancer Treat Rep | 1980 Apr-May |
1 |
| 55 | 7233568 | Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results. | Tumori | 1980 Dec 31 |
2 |
| 56 | 7521788 | Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma. | Cancer | 1994 Oct 1 |
3 |
| 57 | 7530823 | [CHOP-Bleo therapy in high-malignancy non-Hodgkin lymphoma]. | Orv Hetil | 1994 Dec 11 |
1 |
| 58 | 7563607 | [Multicentric Castleman's disease with lymphoid interstitial pneumonia died of aggressive course with adult respiratory distress syndrome]. | Rinsho Ketsueki | 1995 Aug |
1 |
| 59 | 7590500 | A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma. | Haematologica | 1995 Jul-Aug |
1 |
| 60 | 7595704 | Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. | J Clin Oncol | 1995 Oct |
1 |
| 61 | 7645021 | Glutathione depletion in human T lymphocytes: analysis of activation-associated gene expression and the stress response. | Toxicol Appl Pharmacol | 1995 Aug |
1 |
| 62 | 7655111 | The effect of acute and chronic photodamage on gene expression in human keratinocytes. | Dermatology | 1995 |
1 |
| 63 | 7680764 | Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. | N Engl J Med | 1993 Apr 8 |
4 |
| 64 | 7703552 | [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature]. | Bull Cancer | 1994 Apr |
1 |
| 65 | 7796361 | Primary non-Hodgkin's lymphoma of the mediastinum: a clinicopathological report of six cases. | Zhonghua Yi Xue Za Zhi (Taipei) | 1995 Apr |
1 |
| 66 | 7813278 | Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. | Chest | 1995 Jan |
1 |
| 67 | 7898521 | Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. | N Engl J Med | 1995 Apr 20 |
2 |
| 68 | 7936304 | Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. | Neurology | 1994 Sep |
1 |
| 69 | 7981060 | Induction of the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in vitro and in vivo. | Br J Cancer | 1994 Dec |
1 |
| 70 | 7987849 | Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. | Cancer Res | 1994 Dec 15 |
2 |
| 71 | 8038494 | Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL. | Baillieres Clin Haematol | 1993 Dec |
4 |
| 72 | 8058339 | Rare variant (Glu to Lys) in the leucine zipper region of CHOP (GADD153). | Oncogene | 1994 Sep |
6 |
| 73 | 8076711 | Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. | Eur J Surg Oncol | 1994 Aug |
3 |
| 74 | 8168107 | The p53-dependent gamma-ray response of GADD45. | Cancer Res | 1994 May 15 |
1 |
| 75 | 8236992 | [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma]. | Wiad Lek | 1993 May |
1 |
| 76 | 8239684 | [Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas]. | Gan To Kagaku Ryoho | 1993 Nov |
1 |
| 77 | 8285167 | [Malignant lymphoma of the prostate--a case report]. | Hinyokika Kiyo | 1993 Dec |
2 |
| 78 | 8336711 | Regulation of the C/EBP-related gene gadd153 by glucose deprivation. | Mol Cell Biol | 1993 Aug |
3 |
| 79 | 8369658 | Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. | Thyroid | 1993 Summer |
4 |
| 80 | 8426200 | Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. | J Clin Oncol | 1993 Feb |
2 |
| 81 | 8431969 | Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity. | Cancer Chemother Pharmacol | 1993 |
1 |
| 82 | 8469201 | Adult T cell leukaemia lymphoma in a non-aboriginal Australian woman with no apparent risk factors. | Med J Aust | 1993 Apr 5 |
3 |
| 83 | 8523055 | High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. | J Clin Oncol | 1995 Dec |
2 |
| 84 | 8554977 | Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153. | Br J Cancer | 1996 Jan |
15 |
| 85 | 8558202 | CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial. | J Clin Oncol | 1996 Jan |
1 |
| 86 | 8622660 | Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. | Mol Cell Biol | 1996 Mar |
18 |
| 87 | 8629263 | [High-grade non-Hodgkin lymphoma: diagnosis and therapy]. | Ther Umsch | 1996 Feb |
4 |
| 88 | 8636770 | Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. | J Clin Oncol | 1996 Feb |
1 |
| 89 | 8650547 | Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. | Science | 1996 May 31 |
1 |
| 90 | 8652232 | Non-Hodgkin's lymphomas--current status of therapy and future perspectives. | Eur J Cancer | 1995 Dec |
3 |
| 91 | 8670069 | Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. | Biochem J | 1996 Mar 1 |
15 |
| 92 | 8688344 | A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report. | Br J Cancer | 1996 Jul |
3 |
| 93 | 8702804 | Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding site. | J Biol Chem | 1996 Aug 23 |
3 |
| 94 | 8754828 | Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). | Mol Cell Biol | 1996 Aug |
2 |
| 95 | 8892739 | Association of primary renal non-Hodgkin's lymphoma with mesangioproliferative glomerulonephritis. | Am J Hematol | 1996 Oct |
1 |
| 96 | 8892753 | Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation. | DNA Cell Biol | 1996 Oct |
2 |
| 97 | 8978792 | [Effective clinical use of cyclophosphamide in hematological malignancies]. | Gan To Kagaku Ryoho | 1996 Dec |
1 |
| 98 | 8996528 | DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. | Cancer Chemother Pharmacol | 1997 |
7 |
| 99 | 9038301 | Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. | Infect Immun | 1997 Mar |
2 |
| 100 | 9044846 | Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. | Cancer Res | 1997 Feb 15 |
5 |